Keyphrases
Cisplatin
100%
Ifosfamide
100%
Doxorubicin
100%
Plasma Parameters
100%
L-carnitine
100%
Preadolescent children
100%
Chemotherapy
50%
Prior Chemotherapy
25%
Young Cancer Patients
25%
Carnitine Level
25%
Cancer Center
12%
Metabolism
12%
Newly Diagnosed
12%
Children with Cancer
12%
Cancer-related Fatigue
12%
Bloodstream
12%
Adenosine Triphosphate
12%
Cisplatin-based Chemotherapy
12%
Newly Diagnosed Patients
12%
Carnitine Deficiency
12%
Doxorubicin Treatments
12%
Pharmacology, Toxicology and Pharmaceutical Science
Doxorubicin
100%
Cisplatin
100%
Ifosfamide
100%
Carnitine
100%
Chemotherapy
50%
Malignant Neoplasm
40%
Patient History of Chemotherapy
20%
Carnitine Deficiency
10%
Adenosine Triphosphate
10%
Neuroscience
Cisplatin
100%
Carnitine
100%
Ifosfamide
100%
Blood Plasma
100%
Doxorubicin
100%
Adenosine Triphosphate
9%
Metabolic Pathway
9%
Biochemistry, Genetics and Molecular Biology
Cisplatin
100%
Blood Level
100%
Ifosfamide
100%
Doxorubicin
100%
Metabolic Pathway
33%
Adenosine Triphosphate
33%